You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-HDAC-GSK-3117391
GSK-3117391

Chemical Structure : GSK-3117391

CAS No.: 1018673-42-1

GSK-3117391 (ESM-HDAC391;CHR-5154;GSK3117391;CHR5154)

Catalog No.: PC-63389Not For Human Use, Lab Use Only.

GSK-3117391 (ESM-HDAC391, CHR-5154) is an orally active, myeloid-targeted histone deacetylase (HDAC) inhibitor with IC50 of 55 nM in a HeLa cell nuclear extract fluorometric assay, potently inhibits Class I, Class IIb and Class IV members (HDAC 1/2/3/8, HDAC6/10, and HDAC 11, respectively), with Class IIa enzymes (HDAC4/5/7/9) unaffected.

Packing Price Stock Quantity
5 mg $248 In stock
10 mg $398 In stock
25 mg $598 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GSK-3117391 (ESM-HDAC391, CHR-5154) is an orally active, myeloid-targeted histone deacetylase (HDAC) inhibitor with IC50 of 55 nM in a HeLa cell nuclear extract fluorometric assay, potently inhibits Class I, Class IIb and Class IV members (HDAC 1/2/3/8, HDAC6/10, and HDAC 11, respectively), with Class IIa enzymes (HDAC4/5/7/9) unaffected.
GSK-3117391 (ESM-HDAC391, CHR-5154) increases global acetylation in monocytes in human whole blood with EC50 of 158 nM, with marked selectivity over other leucocyte populations.
GSK-3117391 (ESM-HDAC391, CHR-5154) inhibits TNFα production in LPS-stimulated blood (IC50=174 nM).
GSK-3117391 (ESM-HDAC391, CHR-5154) shows rapid conversion to acid metabolite HDAC189 in carboxylesterase-1-expressing cells.
GSK-3117391 (ESM-HDAC391, CHR-5154) is a novel targeted inhibitor demonstrating sustained potent mechanistic engagement and antiinflammatory activity.

Physicochemical Properties

M.Wt 389.496
Formula C21H31N3O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

cyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate

References

1. Rebecca C Furze, et al. Br J Clin Pharmacol. 2022 Jun 2. doi: 10.1111/bcp.15428.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: